Labshake search
Citations for R&D Systems :
251 - 300 of 3412 citations for Methylphosphonic Acid 13C 99%; Methyl D3 98% 100 Ug Ml In Methanol since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript ...
-
bioRxiv - Neuroscience 2022Quote: ... and 100 ng/mL OX-2 membrane glycoprotein (CD200) (R&D systems, cat.no. 27712CD050) growth factors in addition to the previously described growth factors.
-
bioRxiv - Immunology 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse epidermal growth factor (100 ng/ml) (R&D Systems, #2028-EG-200). Cells were plated in a six-well dish at a density of about 2 retinas per 10cm2 well ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Cell Biology 2024Quote: ... cells were stimulated with 100 ng/mL recombinant WNT3A (R&D Systems, 5036-WN) or WNT5A (R&D Systems ...
-
bioRxiv - Genomics 2024Quote: ... cells were also treated with or without TNFα (R&D systems, 100 ng/ml) at 48 h after transfection and harvested at 72 h after transfection (24 h after TNFα treatment).
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... penicillin-streptomycin) supplemented with 100 ng/mL EGF (R&D Systems, cat # 236-EG) and 100 ng/mL of BMP2 (R&D Systems ...
-
bioRxiv - Microbiology 2023Quote: ... 100 µg/ml streptomycin and either 5 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems, Abingdon, UK) to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Microbiology 2023Quote: ... ligand-loaded CD1d (0.25 ug per well) was bound onto Streptavidin-coated plates (R&D Systems #CP003). Plates were washed with PBS three times and then added 24.7 NKT cells (4 x 104∼105 per well ...
-
bioRxiv - Synthetic Biology 2021Quote: ... in a 1:1 ratio with 100 U mL-1 of IL-7 and 10U mL-1 IL-15 (R&D Systems) in tissue culture flasks ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Developmental Biology 2019Quote: ... and 100 ng/ml CHO-derived mouse R-spondin 1 or 5 ng/ml CHO-derived mouse R-spondin 2 (R&D System). The final concentration of Rspondins in the culture medium was initially tested in pilot experiments in order to add comparable amounts of bioactive ligands (bioactivity measured by TOPflash assays and organoid growth curves ...
-
bioRxiv - Immunology 2020Quote: ... and then re-suspended in 30 μL of media containing 10,000 units/mL of recombinant IFN-α2a or 100 units/mL of recombinant IFN-γ (R&D Systems). Antibodies against SiglecF ...
-
bioRxiv - Neuroscience 2023Quote: ... or bFGF (10 ng/mL) and diazepam (100 μM) (045-18901, Wako) or BMP4 (50 ng/mL) (5020-BP, R&D Systems) (quiescence medium ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Neuroscience 2021Quote: ... the supplements in the medium were replaced with FGF8 (100 ng/ml; R&D Systems). From day 11 ...
-
bioRxiv - Genomics 2022Quote: ... 15140122) supplemented with final 100 ng/ml Activin-A (R&D Systems, 338-AC-01M) and 1,4 µg/ml CHIR99021 (Stemgent ...
-
bioRxiv - Bioengineering 2023Quote: ... iASCs were prepared by pretreating ASCs with interferon γ (100 ng/ml; R&D Systems) in ASC culture medium for 24 hours ...
-
bioRxiv - Genomics 2023Quote: ... (Thermo Fisher Scientific)] medium supplemented with recombinant human/mouse/rat activin A (100 ng/mL; R&D Systems) for 18 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... alone or sequentially with 100 μL/mL polylysine and 400 ng/mL netrin-1 (R&D systems, catalog number 6419-N1-025/CF), and cultured in Neurobasal Medium (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2020Quote: ... Glass coverslips were coated with alternating stripes (IgG or Sema7a 100 μg/ml, R&D Systems), which were then covered by laminin (20 μg/ml) ...
-
bioRxiv - Cell Biology 2020Quote: ... 5μM Y-27632 and 100 ng/ml recombinant mouse Noggin (R&D Systems, 1967-NG-025)) ...
-
bioRxiv - Immunology 2023Quote: ... CTL medium containing 100 IU/ml human IL-2 (R&D Systems, 202-IL-010/CF) was added to the plates and the expansion of T cells continued ...
-
bioRxiv - Genetics 2023Quote: ... in presence or absence of IFN γ (R&D Systems, 485-MI-100, 10 ng/ml). On day 2 of reprogramming ...
-
bioRxiv - Genetics 2023Quote: ... in presence or absence of IFN γ (R&D Systems, 485-MI-100, 10 ng/ml) for the first 5 days ...
-
bioRxiv - Cell Biology 2023Quote: ... starved overnight and exposed to 1.5 ng/ml of TFGβ (#100-B-001, R&D Systems) for 6 and 24 hours ...
-
bioRxiv - Biochemistry 2023Quote: ... and 10 ng/mL recombinant mouse interferon-γ (IFN-γ) (R&D Systems, 485-MI-100) were added to the media and maintained with subsequent media change.
-
bioRxiv - Cell Biology 2024Quote: ... Purified human recombinant HGF (100-250 ng/ml, as indicated) was obtained from R&D Systems. Protein-A Gold 10 nm was from Utrecht University ...
-
bioRxiv - Immunology 2024Quote: ... #CCL-131) were plated in each well of 96-well plates and preactivated with 100 ng/mL mouse IFN-γ (R&D Systems, #485-MI-100) for 18-24 hours ...
-
bioRxiv - Genomics 2024Quote: ... 5 mM beta-glycerophosphate and 1% insulin-transferrin-selenous acid (osteogenic media) and stimulated them the next day with recombinant human BMP2 (300 ng/ml) (R&D Systems, MN) in serum-free osteogenic media ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 100 µl) in N2-S medium supplemented with 20 ng/ml EGF and 20 ng/ml FGF2 (both from R&D Systems, Minneapolis, Minnesota, USA) into the upper chamber ...
-
bioRxiv - Neuroscience 2021Quote: ... The neural medium was supplemented with 10 ng/mL epidermal growth factor (PreproTech, AF-100-15) and 10 ng/mL basic fibroblast growth factor (R&D Systems, 234-FSE-025) and changed daily until day 12 ...
-
bioRxiv - Molecular Biology 2022Quote: ... The neural medium was supplemented with 10 ng/mL epidermal growth factor (PreproTech AF-100-15) and 10 ng/mL basic fibroblast growth factor (R&D Systems 234-FSE-025). From day 6 to day 10 the medium was changed everyday until the appearance of rosettes ...
-
bioRxiv - Cell Biology 2023Quote: ... osteoclast differentiation was initiated using αMEM complete media supplemented with 30 ng/mL M-CSF and 100 ng/mL RANKL (R&D Systems, 462-TEC/CF)(57) ...
-
bioRxiv - Cancer Biology 2019Quote: ... medium was supplemented with a growth factor cocktail for recovery (100 ng/ml EGF (R&D Systems), 100 ng/ml FGF1 (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... and 2.5 ng/ml recombinant mouse IL-15 and 100 units of IL-2 (R&D Systems).
-
bioRxiv - Bioengineering 2021Quote: ... 100 ng/mL human Fms-related tyrosine kinase 3 ligand (Flt3L, #308-FK, all R&D Systems), 2 mM L-GlutaMAX (Gibco #35050-038) ...
-
bioRxiv - Physiology 2019Quote: ... and then treated with DM containing 100 ng/ml of IGF1 (R&D Systems, Minneapolis, MN, USA), PD98059 (50 μM ...
-
bioRxiv - Microbiology 2021Quote: ... surface blocking was conducted by incubated surfaces with anti-NgR1 antibody (R&D Systems; 100 µg/mL). Measurements were taken at a retraction velocity of 1 µm/s ...
-
bioRxiv - Immunology 2022Quote: ... 1% PS and 100 IU/ml of human recombinant IL-2 (R&D Systems, 202-IL-050). Cells were used at low passage numbers ...
-
bioRxiv - Microbiology 2023Quote: ... cells were stimulated or not with 100 ng/ml mouse IL-17 recombinant protein (R&D Systems) for 10 or 30 min ...
-
Suppression of the Integrated Stress Response in Islet β Cells Decreases Risk of Autoimmune DiabetesbioRxiv - Cell Biology 2023Quote: ... the proinflammatory cytokine cocktail contained 1000 IU/mL human IFN-γ (R&D Systems; 285-IF-100) and 50 IU/mL human IL-1β (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... Caffeic acid phenethyl ester (CAPE) (R&D Systems), Mitoquinone (MitoQ ...
-
bioRxiv - Developmental Biology 2024Quote: ... samples were fixed for 10 min in ice-cold methanol and incubated with primary antibodies (goat E-cadherin, R&D systems) and nuclear stain (Hoechst ...
-
bioRxiv - Neuroscience 2020Quote: ... anterior primitive streak was first specified using 100 ng/ml Activin A (R&D systems, 338-AC-050), 3 µm CHIR (Tocris ...
-
bioRxiv - Cancer Biology 2022Quote: Mouse primary GBM cell lines were treated with 100 pM IL-1β (R&D Systems, 401-ML/CF) for 10 ...